|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.44/-0.59
|
企业价值
496.82M
|
资产负债 |
每股账面净值
0.59
|
现金流量 |
现金流量率
--
|
损益表 |
收益
18.14M
|
每股收益
0.12
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/04/24 21:04 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology. |